Welcome to Crene Biotechnology!

+86-576-88205808

Catalog No CAS NO Product name
CS0173
1158279-20-9
HLCL-61 HCL
HLCL-61 is a potent and selective PRMT5 inhibitor for treatment of acute myeloid leukemia. HLCL-61 resulted in significantly incre..
CS0171
349085-82-1
GSK137647A
GSK137647A is an agonist of the free fatty acid receptor 4 (FFA4/GPR120) with pEC50s = 6.3, 6.2, and 6.1 at human, mouse, and rat ..
CS0170
1228585-88-3
GS-9620 Vesatolimod
Vesatolimod, also known as GS-9620, is a potent and oral agonist of Toll-like receptor-7 developed for finite treatment of chronic..
CS0169
1362154-70-8
GNE-617
GNE-617 is a potent nicotinamide phosphoribosyltransferase (NAMPT) inhibitor with IC50 value of 5nM. Prolonged inhibition of nicot..
CS0168
1496581-76-0
GNE-3511
GNE-3511 is a potent and selective dual leucine zipper kinase (DLK, MAP3K12) inhibitors with activity in neurodegeneration models...
CS0167
1446321-46-5
GBT440 Voxelotor
Voxelotor, also known as GBT-440, is a hemoglobin S allosteric modulator. GBT440 Inhibits Sickling of Sickle Cell Trait Blood Unde..
CS0166
945714-67-0
FPS-ZM1
FPS-ZM1 is a high-affinity RAGE-specific blocker that inhibits amyloid-β binding to RAGE, neurological damage and inflammation in..
CS0165
1616392-22-3
GSK3326595 EPZ015938
GSK-3326595, also known as EPZ015938, is an orally active, potent and selective inhibitor of protein arginine methyltransferase 5 ..
CS0164
1616391-65-1
EPZ015666 GSK3235025
EPZ015666, also known as GSK3235025, is a potent and selective and orally active PRMT5 inhibitor with a half-maximal inhibitory co..
CS0161
1884712-47-3
CPI-637
CPI-637 is a potent and selective CBP/ EP300 bromodomain inhibitor. The biochemical potency of CPI-637 translated well into cells ..
首页上一页当前第93/189页共1887条记录每页10条9192939495下一页尾页
Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.
Friendly link:

Copyright Copyright (C) 2018-2021Taizhou Crene Biotechnology Co., Ltd.

Address:Economic Developed Zone of Taizhou Zhejiang China.